GS
Glen D. Stettin
Sr. VP, Clin. Res. & New Sol.

Glen D. Stettin insider trades: Express Scripts Holding (ESRX) stock sales

Sr. VP, Clin. Res. & New Sol., Express Scripts Holding Last trade Jan 11, 2018 32 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2014
4
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Glen reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 11, 2018ESRX↓ Sell$279K
Jan 2, 2018ESRX↓ Sell$262K
Mar 2, 2015ESRX↓ Sell$226K
Feb 25, 2015ESRX↓ Sell$2.4M
Nov 28, 2014ESRX↓ Sell$896K
Nov 21, 2014ESRX↓ Sell$886K
Mar 7, 2014ESRX↓ Sell$3.4M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Glen D. Stettin's insider trades

Glen D. Stettin is Sr. VP, Clin. Res. & New Sol. at Express Scripts Holding (ESRX). Since Mar 7, 2014, Glen has reported no open-market purchases and 7 sales worth $8.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (18 filings), shares withheld for taxes (10 filings), option exercises (5 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ESRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.